Skip to main content

Capital Finance

By Rene Letourneau | 09:20 am | January 25, 2012
In 2011, a total of $227.4 billion was committed to financing healthcare merger, acquisition and takeover activity, representing an 11 percent increase over the $205.6 billion spent in 2010, according to a new report from Irving Levin Associates, Inc.
By Rene Letourneau | 08:47 am | January 25, 2012
Twenty-two percent of healthcare IT and pharma mergers and acquisitions in 2011 were financed by private equity, venture capital and other investment firms, according to a new report from investment bank Berkery Noyes.
By Stephanie Bouchard | 09:59 am | January 23, 2012
Duke LifePoint Healthcare and Virginia-based Twin County Regional Healthcare (TCRH) have entered into a definitive agreement that will pump millions into TCRH and its community.
By Rene Letourneau | 02:46 pm | January 22, 2012
Workforce management firm Kronos Incorporated announced Friday that it has acquired the assets of OptiLink from The Advisory Board Company in a cash transaction.
By Chris Anderson | 10:45 am | January 12, 2012
In a combination of two companies focused on developing new patient-centered care models, Paladina Health today announced the acquisition of ModernMed, a primary care operator with locations in 12 states.
By Mike Miliard | 10:09 am | January 12, 2012
Universal American Corp. announced Wednesday plans to acquire APS Healthcare for $227.5 million.
By Stephanie Bouchard | 09:59 am | January 12, 2012
Former chief financial officer of HealthSouth, Aaron Beam, was flying high until he became involved in an accounting fraud that would send him to jail and offer him a mission: warning others of the ethical dangers of wealth and success.
By Chris Anderson | 10:51 am | January 11, 2012
Med Data Inc., a provider of medical billing services has acquired revenue cycle management and personalized patient communications company MedDirect, Inc.
By Chris Anderson | 10:35 am | January 09, 2012
Tenet Healthcare Corporation today projected that its 2012 adjusted earnings before interest, taxes and depreciation (EBITDA) would be in the range of $1.2 billion to $1.3 billion, a moderate uptick from its expected EBITDA for 2011.
By Rene Letourneau | 02:14 pm | January 06, 2012
The U.S. market for orthopedic biomaterials will grow at an average of just under 7 percent per year, to total approximately $4 billion by 2016, predicts medical technology market research firm Millennium Research Group (MRG).